Paul Melmeyer Orphan Drug Act

Rare Disease Legislation: A Historical Primer |

Paul Melmeyer

#SaveOrphanDrugs -- Lastest Update from Paul Melmeyer

Health Canada plans to introduce its

Douglas

It's been three decades since

Douglas

Emil Kakkis, MD, President and Founder of Ultragenyx Pharmaceutical Inc., explains that while the

Incentivizing Innovation for Rare Disease Treatment Development | Thursday, May 18th, 2017.

Video abstract of review paper "A 30-year retrospective: National Organization for Rare Disorders, the

Douglas

... rare disease community since the passing of the

From all of us at NORD, we'd like to say a huge thank you to our advocates who took the time over the past few months to ...

Watch the presentation to hear us discuss the importance of the

Rare Disease

Here are some of the highlights since the

March 21, 2016 - Future Directions for Undiagnosed Diseases Research: The UDN and Beyond More: ...

Experts will take a deep dive into the incentives in the

... policies related to rare disease and orphan drug development and then

Rare Disease Day: A Look at 40 Years of the